OI
AGN

Oakbrook Investments’s Allergan plc AGN Stock Holding History

Oakbrook Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$221K Sell
1,250
-2,650
-68% -$499K 0.56% 68
2019
Q4 		$746K Sell
3,900
-4,900
-56% -$884K 0.15% 202
2019
Q3 		$1.48M Sell
8,800
-1,525
-15% -$248K 0.1% 153
2019
Q2 		$1.73M Sell
10,325
-8,875
-46% -$1.23M 0.1% 149
2019
Q1 		$2.81M Sell
19,200
-1,150
-6% -$167K 0.17% 95
2018
Q4 		$2.72M Buy
20,350
+1,480
+8% +$243K 0.18% 92
2018
Q3 		$3.59M Sell
18,870
-755
-4% -$139K 0.2% 80
2018
Q2 		$3.27M Buy
19,625
+6,872
+54% +$1.1M 0.21% 81
2018
Q1 		$2.15M Buy
12,753
+655
+5% +$110K 0.13% 124
2017
Q4 		$1.98M Sell
12,098
-5,650
-32% -$1.01M 0.13% 123
2017
Q3 		$3.64M Sell
17,748
-3,225
-15% -$750K 0.23% 77
2017
Q2 		$5.1M Buy
20,973
+19,550
+1,374% +$4.59M 0.34% 60
2017
Q1 		$340K Sell
1,423
-17,945
-93% -$4.18M 0.02% 411
2016
Q4 		$4.07M Sell
19,368
-7,088
-27% -$1.47M 0.27% 73
2016
Q3 		$6.09M Sell
26,456
-3,550
-12% -$867K 0.37% 59
2016
Q2 		$6.93M Sell
30,006
-5,200
-15% -$1.2M 0.38% 60
2016
Q1 		$9.44M Buy
35,206
+993
+3% +$284K 0.61% 43
2015
Q4 		$10.7M Sell
34,213
-2,821
-8% -$840K 0.68% 41
2015
Q3 		$10.1M Buy
37,034
+13,200
+55% +$4.05M 0.66% 38
2015
Q2 		$7.23M Buy
23,834
+4,343
+22% +$1.3M 0.44% 54
2015
Q1 		$5.8M Sell
19,491
-178
-0.9% -$50.7K 0.31% 76
2014
Q4 		$5.06M Sell
19,669
-21,375
-52% -$5.34M 0.27% 81
2014
Q3 		$9.9M Buy
41,044
+12,884
+46% +$2.88M 0.53% 47
2014
Q2 		$6.28M Buy
28,160
+801
+3% +$166K 0.19% 130
2014
Q1 		$5.63M Sell
27,359
-36,632
-57% -$7.26M 0.18% 135
2013
Q4 		$10.8M Buy
63,991
+38,599
+152% +$6.03M 0.3% 84
2013
Q3 		$3.66M Sell
25,392
-1,675
-6% -$223K 0.11% 201
2013
Q2 		$3.42M Buy
+27,067
New +$3.06M 0.1% 222

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oakbrook Investments's AGN Position: Q1 2020 in Review

Oakbrook Investments reduced its Allergan plc (AGN) stake by 68% in Q1 2020, selling an estimated $499K and leaving 1,250 shares worth $221K. The position accounts for 0.56% of the portfolio, ranked #68.

Oakbrook Investments first reported a position in AGN in Q2 2013 and has held it in 28 quarters since. The position peaked at $10.8M in Q4 2013. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Oakbrook Investments held 1,250 shares of Allergan plc worth $221K as of Q1 2020.
  • Oakbrook Investments sold 2,650 Allergan plc shares in Q1 2020, an estimated $499K.
  • Allergan plc made up 0.56% of Oakbrook Investments's portfolio in Q1 2020, its #68 holding.
  • Oakbrook Investments first reported a position in Allergan plc in Q2 2013 and has held it in 28 quarters since.
  • Oakbrook Investments's Allergan plc position peaked at $10.8M in Q4 2013.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.